BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop ...

NewGenIvf Group (NASDAQ:NIVF) is implementing a reverse stock split of all of its issued and unissued shares at an exchange ...

Holdings announced the date of effectiveness and the ratio of a forthcoming reverse stock split of the Company’s Common Stock. On January 13, 2025, the Company announced, on a Current Report on Form 8 ...

BioXcel Therapeutics (BTAI) announced that it will effect a 1-for-16 reverse stock split of its common stock. The reverse stock split will ...

(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...

Mullen Automotive Inc. (NASDAQ:MULN), a player in the motor vehicles and passenger car bodies industry, conducted a Special Meeting of Stockholders where key decisions were made regarding the ...

The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.

The new CUSIP number for the Common Stock following the Reverse Stock Split will be 45824Q705. The material effects of the Reverse Stock Split are: Every 20 shares of Glucotrack’s issued and ...

HARTFORD, Conn.--(BUSINESS WIRE)--Virtus Convertible & Income Fund (NYSE: NCV) and Virtus Convertible & Income Fund II (NYSE: NCZ) announced that a 1-for-4 reverse stock split of the issued and ...

The Funds will retain their trading symbols but have been assigned the following new CUSIP numbers as of the Effective Date: NCV: 92838X805 NCZ: 92838U801 The reverse stock splits are intended to ...